Abstract:BACKGROUND:Gliomas are the most common intracranial tumors and are classified as I-IV. Among them, glioblastoma multiforme (GBM) is the most common invasive glioma with a poor prognosis. New molecular biomarkers that can predict clinical outcomes in GBM patients must be identified, which will help comprehend their pathogenesis and supply personalized treatment. Our research revealed four powerful survival indicators in GBM by reanalyzing microarray data and genetic sequencing data in public databases. Moreover, it unraveled new potential therapeutic targets which could help improve the survival time and quality of life of GBM patients.MATERIALS AND METHODS:To identify prognostic signatures in GBMs, we analyzed the gene profiling data of GBM and standard brain samples from the Gene Expression Omnibus, including four datasets and RNA sequencing data from The Cancer Genome Atlas (TCGA) containing 152 glioblastoma tissues. We performed the differential analysis, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, weighted gene co-expression network analysis (WGCNA) and Cox regression analysis.RESULTS:After differential analysis in GSE12657, GSE15824, GSE42656 and GSE50161, overlapping differentially expressed genes were identified. We identified 110 up-regulated DEGs and 75 down-regulated DEGs in the GBM samples. Significantly enriched subclasses of the GO classification of these genes included mitotic sister chromatid separation, mitotic nuclear division and so on. In KEGG pathway analysis, the most abundant terms were ECM-receptor interaction and protein digestion and absorption. WGCNA analysis was performed on these 185 DEGs in 152 glioblastoma samples obtained from TCGA, and gene co-expression networks were constructed. We then performed a multivariate Cox analysis and established a Cox proportional hazards regression model using the top 20 genes significantly correlated with survival time. We identified a four-protein prognostic signature that could divide patients into high-risk and low-risk groups. Increased expression of SLC12A5, CCL2, IGFBP2, and PDPN was associated with increased risk scores. Finally, the K-M curves confirmed that these genes could be used as independent predictors of survival in patients with glioblastoma.CONCLUSION:Our analytical study identified a set of potential biomarkers that could predict survival and may contribute to successful treatment of GBM patients.

Identifying the miRNA Signature Association with Aging-Related Senescence in Glioblastoma

Identification and Validation of SNHG Gene Signature to Predict Malignant Behaviors and Therapeutic Responses in Glioblastoma

Identify Signature Regulatory Network for Glioblastoma Prognosis by Integrative Mrna and Mirna Co-Expression Analysis.

An Integrated Mrna and Microrna Expression Signature for Glioblastoma Multiforme Prognosis.

Tmic-05. Aging-Specific Microrna Expression Signature In Elderly Glioblastoma

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

MicroRNA Expression Signatures and Their Correlation with Clinicopathological Features in Glioblastoma Multiforme

MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma

miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment

Integrated Analysis of Mutations, Mirna and Mrna Expression in Glioblastoma.

Identification of Dysregulated microRNAs in Glioblastoma Stem-Like Cells

MicroRNA Signatures Predict Prognosis of Patients with Glioblastoma Multiforme Through the Cancer Genome Atlas.

Integrated Analysis to Evaluate the Prognostic Value of Signature Mrnas in Glioblastoma Multiforme

Molecular mechanisms of microRNAs in glioblastoma pathogenesis

Identification of an 8-Mirna Signature As a Potential Prognostic Biomarker for Glioma

Gene and Microrna Signatures Are Associated with the Development and Survival of Glioblastoma Patients.

Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma

Comprehensive Bioinformatics Analysis of Mrna Expression Profiles and Identification of a Mirna-Mrna Network Associated with the Pathogenesis of Low-Grade Gliomas.

Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma

Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic Targets